Group 1 - Liu Delei, the director, vice president, and board secretary of Jincai Huilian, resigned for personal reasons and will no longer hold any position in the company [1] - Jincai Huilian was established in July 1988, focusing on heat treatment equipment manufacturing, commercial heat treatment processing services, after-sales service for heat treatment equipment, and technical consulting for heat treatment processes [1] Group 2 - Wuxi Zhenhua plans to issue convertible bonds totaling 520 million yuan to unspecified investors, with the issuance date set for June 18, 2025 [2] - Wuxi Zhenhua was founded in September 1989, specializing in stamping parts, assembly processing, molds, and selective precision electroplating [2] Group 3 - Biyiwei's shareholder, Yuan Chengjun, intends to transfer 3% of the company's shares through an inquiry-based method due to personal funding needs [3][4] - Biyiwei was established in May 2014, focusing on the design and sales of high-performance analog and mixed-signal integrated circuits [4] Group 4 - Jintian Titanium Industry plans to distribute a cash dividend of 0.84 yuan per 10 shares, totaling 38.85 million yuan [5] - Jintian Titanium Industry was founded in April 2004, specializing in the research, production, and sales of high-end titanium and titanium alloy materials [6] Group 5 - Lingyun Guang intends to distribute a cash dividend of 0.25 yuan per 10 shares [7] - Lingyun Guang was established in August 2002, focusing on the research, production, and sales of machine vision and optical communication [8] Group 6 - Fangbang Co. plans to distribute a cash dividend of 1.8676 yuan per 10 shares [9][10] - Fangbang Co. was founded in December 2010, specializing in the research, production, and sales of high-end electronic materials [10] Group 7 - Bozhong Precision plans to acquire 70% of Shanghai Wodian for 420 million yuan, which will enhance its automotive manufacturing automation business [11] - Bozhong Precision was established in September 2006, focusing on automation equipment and related services [12] Group 8 - Guomao Co.'s actual controllers plan to reduce their holdings by up to 3% of the company's shares due to personal funding needs [12][13] - Guomao Co. was founded in March 2013, specializing in the research, production, and sales of reducers [13] Group 9 - *ST Tongzhou will remove the delisting risk warning and other risk warnings, changing its stock name to Tongzhou Electronics [14] - *ST Tongzhou was established in February 1994, focusing on the development and sales of digital television middleware and smart home-related services [14] Group 10 - Huahai Pharmaceutical received a drug registration certificate for Fumaric Acid Quetiapine Sustained-Release Tablets, used for treating schizophrenia and bipolar disorder [15][16] - Huahai Pharmaceutical was founded in February 2001, specializing in the research, production, and sales of various types of generic drugs and innovative drugs [16] Group 11 - Guosheng Hall's innovative hepatitis B treatment drug has received ethical review approval for its Phase III clinical trial [25][26] - Guosheng Hall was established in June 2001, focusing on the research, production, and sales of nucleoside antiviral drugs [26] Group 12 - Jintian International won a bid for the Zhongguang Nuclear San'ao project, with a contract amount of 22 million yuan [27][28] - Jintian International was founded in October 2000, specializing in smart logistics and intelligent manufacturing solutions [28] Group 13 - Heng Rui Pharmaceutical's director plans to reduce his holdings by up to 47,670 shares due to personal funding needs [29][30] - Heng Rui Pharmaceutical was established in April 1997, focusing on the research, production, and sales of pharmaceuticals [30]